3.9(top 4%)
Impact Factor
4(top 4%)
extended IF
116(top 3%)
H-Index
2.4K
authors
4.6K
papers
97.2K
citations
2.2K
citing journals
36.6K
citing authors
Institutions
| Institution | Articles | Citations | A Rank | C Rank |
|---|---|---|---|---|
| AstraZeneca | 208 | 3.1K | 3 | 25 |
| Pfizer | 169 | 1.9K | 15 | 73 |
| Merck & Co. | 166 | 2.1K | 11 | 96 |
| Eli Lilly and Company | 151 | 2.8K | 10 | 57 |
| GlaxoSmithKline | 148 | 2.6K | 17 | 76 |
| Princeton University | 104 | 350 | 195 | 255 |
| Bristol-Myers Squibb | 79 | 783 | 11 | 60 |
| Amgen | 64 | 598 | 30 | 157 |
| Dow Chemical Company | 57 | 774 | 24 | 51 |
| Janssen Pharmaceuticals | 45 | 293 | 10 | 133 |
| University of Mumbai | 42 | 498 | 12 | 29 |
| Boehringer Ingelheim | 42 | 1K | 13 | 36 |
| Massachusetts Institute of Technology | 40 | 1.7K | 255 | 255 |
| Chinese Academy of Sciences | 40 | 343 | 255 | 255 |
| AbbVie | 38 | 357 | 16 | 50 |
| Zhejiang University of Technology | 35 | 357 | 94 | 159 |
| Genentech | 34 | 138 | 58 | 255 |
| National Center for Scientific Research | 31 | 318 | 255 | 255 |
| Abbott Laboratories | 31 | 1.1K | 63 | 74 |
| Research Triangle Park Foundation | 31 | 1.2K | 255 | 255 |